Amines & Plasticizers Ltd
Amines & Plasticisers is engaged in the production of alkyl alkanolamines, morpholine, alkyl morpholine and gas treating solvents having end-use in oil refineries, natural gas plants, ammonia plants, petrochemical plants, pharmaceuticals and agrochemicals. The Company manufactures over 50 different varieties of amines and Agrochemicals. [1] [2]
- Market Cap ₹ 1,429 Cr.
- Current Price ₹ 262
- High / Low ₹ 360 / 146
- Stock P/E 35.6
- Book Value ₹ 42.3
- Dividend Yield 0.19 %
- ROCE 23.2 %
- ROE 19.7 %
- Face Value ₹ 2.00
Pros
Cons
- The company has delivered a poor sales growth of 7.23% over past five years.
- Dividend payout has been low at 9.81% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
192 | 243 | 300 | 260 | 295 | 326 | 455 | 399 | 442 | 563 | 593 | 645 | 653 | |
178 | 225 | 278 | 237 | 267 | 298 | 421 | 357 | 389 | 523 | 551 | 576 | 584 | |
Operating Profit | 14 | 17 | 22 | 23 | 28 | 28 | 34 | 42 | 53 | 40 | 42 | 69 | 70 |
OPM % | 7% | 7% | 7% | 9% | 10% | 9% | 7% | 10% | 12% | 7% | 7% | 11% | 11% |
1 | 1 | 1 | 1 | 2 | 5 | 3 | 1 | 5 | 5 | 1 | 2 | 1 | |
Interest | 9 | 9 | 10 | 8 | 6 | 7 | 8 | 9 | 10 | 9 | 10 | 13 | 11 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 5 |
Profit before tax | 4 | 7 | 12 | 14 | 22 | 24 | 27 | 31 | 44 | 32 | 28 | 53 | 54 |
Tax % | 28% | 30% | 33% | 32% | 29% | 35% | 35% | 19% | 26% | 26% | 26% | 26% | |
3 | 5 | 8 | 10 | 15 | 15 | 17 | 25 | 33 | 24 | 21 | 39 | 40 | |
EPS in Rs | 0.57 | 0.92 | 1.40 | 1.78 | 2.81 | 2.81 | 3.14 | 4.50 | 5.95 | 4.32 | 3.79 | 7.14 | 7.30 |
Dividend Payout % | 9% | 11% | 7% | 11% | 11% | 11% | 10% | 7% | 7% | 9% | 13% | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 7% |
3 Years: | 13% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | 23% |
5 Years: | 18% |
3 Years: | 6% |
TTM: | 42% |
Stock Price CAGR | |
---|---|
10 Years: | 41% |
5 Years: | 51% |
3 Years: | 31% |
1 Year: | 71% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 19% |
3 Years: | 16% |
Last Year: | 20% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
Reserves | 23 | 27 | 34 | 37 | 49 | 62 | 77 | 97 | 130 | 152 | 170 | 207 | 222 |
48 | 48 | 56 | 53 | 52 | 45 | 67 | 58 | 74 | 72 | 85 | 85 | 80 | |
51 | 61 | 41 | 39 | 46 | 67 | 88 | 65 | 91 | 75 | 74 | 83 | 93 | |
Total Liabilities | 127 | 141 | 137 | 140 | 157 | 185 | 244 | 232 | 306 | 310 | 340 | 386 | 406 |
24 | 29 | 30 | 29 | 36 | 40 | 43 | 75 | 73 | 84 | 80 | 80 | 81 | |
CWIP | 1 | 1 | 0 | 0 | 1 | 1 | 11 | 3 | 11 | 3 | 5 | 3 | 2 |
Investments | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
101 | 110 | 105 | 109 | 120 | 144 | 189 | 154 | 221 | 223 | 254 | 302 | 322 | |
Total Assets | 127 | 141 | 137 | 140 | 157 | 185 | 244 | 232 | 306 | 310 | 340 | 386 | 406 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
7 | 17 | 4 | 12 | 11 | 21 | 9 | 37 | 44 | -28 | 3 | 47 | |
-3 | -6 | -2 | -0 | -3 | -1 | -13 | -23 | -6 | -4 | -2 | -1 | |
-4 | -10 | -2 | -12 | -8 | -16 | 10 | -23 | 6 | -13 | 1 | -15 | |
Net Cash Flow | -0 | 1 | 0 | -0 | 0 | 4 | 5 | -8 | 44 | -44 | 1 | 30 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 68 | 62 | 48 | 54 | 55 | 49 | 62 | 63 | 73 | 66 | 75 | 56 |
Inventory Days | 97 | 77 | 61 | 63 | 76 | 98 | 65 | 84 | 73 | 81 | 66 | 76 |
Days Payable | 109 | 100 | 56 | 61 | 72 | 92 | 83 | 76 | 100 | 56 | 52 | 57 |
Cash Conversion Cycle | 55 | 39 | 54 | 57 | 60 | 55 | 43 | 71 | 47 | 91 | 90 | 75 |
Working Capital Days | 85 | 65 | 72 | 84 | 79 | 69 | 61 | 75 | 70 | 95 | 110 | 106 |
ROCE % | 18% | 21% | 24% | 22% | 27% | 27% | 25% | 26% | 28% | 18% | 15% | 23% |
Documents
Announcements
-
Intimation Of Receipt Of Communication From The Stock Exchanges
8m - Notice received for non-compliance and fine payment.
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
19 Nov - Issuance of duplicate share certificates approved.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Intimation To Members Regarding Circulation Of Form DPT-1, I.E., Circular Inviting Unsecured Deposits From Members.
18 Nov - Intimation of unsecured deposit scheme for shareholders.
-
Intimation Of Under Regulation 30 Of SEBI (LODR) Regulations, 2015
18 Nov - Withholding final dividend due to non-compliant KYC.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Nov - Submission of Newspaper publication - Extract of Unaudited (Standalone & Consolidated) Financial of results for the Quarter and Half yearly ended September 30, 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio
The Company manufactures over 60 different varieties of organic chemicals/amines/solvents /fertilizers. The main products manufactured are Methyl Diethonalamine (MDEA) and N Methyl Morpholine Oxide (NMMO) which are used in Petrochemicals and Oil refineries, Gas plants, and Textiles. [1]
During FY22, Co ventured into trading of molecular sieves which are used in Industrial Gases, Fuel Ethanol Production, miscellaneous petrochemicals, a liquid used in an oxygen concentrator, drying agent, packaging industries, polymer processing, and many such industries. [2]